ARCHIVES

Gleevec Approved For Pediatric CML

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

National Cancer Act: Early Promises Were Overstated

May 15, 1998

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Subcommittee chairman Critical Of DCR For Lack Of “Game Plan”

October 28, 1977

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

Alan Rabson Named Acting NCI Director

October 5, 2001